Evidence map›Paper›PMID 32054692›Full record

ReviewJournal of the American Society of Nephrology : JASN2020

Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery.

Mallika L Mendu, Sri Lekha Tummalapalli, Krista L Lentine, Kevin F Erickson, Susie Q Lew, Frank Liu, Edward Gould, Michael Somers, Pranav S Garimella, Terrence O'Neil and 4 more

Open access · greenAbstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. How to Leverage Implementation Science to Achieve Equity in Nephrology Care Delivery.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Article
  4. Population Health Management for Improving Kidney Health Outcomes.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Article
  5. Article
  6. Article
  7. Pay-for-performance programs effectiveness in healthcare: the case of the end-stage renal disease quality incentive program.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. The COVID-19 Pandemic Converges With Kidney Policy Transformation: Implications for CKD Population Health.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 13 institutions in 1 country.

Mallika L MenduDivision of Renal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; mmendu@bwh.harvard.edu.
Sri Lekha TummalapalliDivision of Nephrology, University of California, San Francisco, San Francisco, California.
Krista L LentineSaint Louis University Center for Abdominal Transplantation, St. Louis, Missouri.
Kevin F EricksonSelzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-2164-609X
Susie Q LewDivision of Renal Diseases and Hypertension, George Washington University, Washington, DC.
Frank LiuThe Rogosin Institute, New York, New York.
Edward GouldDivision of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee.
Michael SomersDivision of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Pranav S GarimellaDivision of Nephrology-Hypertension, University of California, San Diego, San Diego, California.ORCID 0000-0002-6016-4715
Terrence O'NeilNephrology Service and Dialysis Unit, Mountain Home Veteran Affairs Medical Center, Mountain Home, Tennessee.
David L WhiteAmerican Society of Nephrology, Washington, DC.
Rachel MeyerAmerican Society of Nephrology, Washington, DC.
Scott D BieberDivision of Nephrology, Department of Medicine, Harborview Medical Center, University of Washington, Seattle, Washington; and.
Daniel E WeinerDivision of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts.
American Society of Nephrology · USBaylor College of Medicine · USBoston Children's Hospital · USBrigham and Women's Hospital · USCornell University · USGeorge Washington University · USMountain Home VA Healthcare System · USSaint Louis University · USTufts Medical Center · USUniversity of California San Diego · USUniversity of California, San Francisco · USUniversity of Washington · USVanderbilt University Medical Center · US

Funding

Tubular secretion, kidney disease progression, and drug dosing in older adultsK23DK114556 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GARIMELLA, PRANAV · 2018 to 2022
$1.0M
Screening Strategies for Chronic Kidney Disease in US PopulationsF32DK122627 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI TUMMALAPALLI, SRI LEKHA · 2019 to 2021
$159k
NIDDK NIH HHS F32 DK122627NIDDK NIH HHS K23 DK114556
6 · The paper itself

Abstract

backgroundLeveraging quality metrics can be a powerful approach to identify substantial performance gaps in kidney disease care that affect patient outcomes. However, metrics must be meaningful, evidence-based, attributable, and feasible to improve care delivery. As members of the American Society of Nephrology Quality Committee, we evaluated existing kidney quality metrics and provide a framework for quality measurement to guide clinicians and policy makers.

methodsWe compiled a comprehensive list of national kidney quality metrics from multiple established kidney and quality organizations. To assess the measures' validity, we conducted two rounds of structured metric evaluation, on the basis of the American College of Physicians criteria: importance, appropriate care, clinical evidence base, clarity of measure specifications, and feasibility and applicability.

resultsWe included 60 quality metrics, including seven for CKD prevention, two for slowing CKD progression, two for CKD management, one for advanced CKD and kidney replacement planning, 28 for dialysis management, 18 for broad measures, and two patient-reported outcome measures. We determined that on the basis of defined criteria, 29 (49%) of the metrics have high validity, 23 (38%) have medium validity, and eight (13%) have low validity.

conclusionsWe rated less than half of kidney disease quality metrics as highly valid; the others fell short because of unclear attribution, inadequate definitions and risk adjustment, or discordance with recent evidence. Nearly half of the metrics were related to dialysis management, compared with only one metric related to kidney replacement planning and two related to patient-reported outcomes. We advocate refining existing measures and developing new metrics that better reflect the spectrum of kidney care delivery.

Indexed as

Delivery of Health CareQuality ImprovementBenchmarkingFemaleHumansKidney Failure, ChronicMalePatient CareRenal DialysisRenal Insufficiency, ChronicUnited Stateschronic kidney diseaseend-stage renal diseaseQuality ImprovementQuality Metrics

Identifiers

PMID32054692
PMCPMC7062216
OpenAlexW3006280313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.